Sorin group (b)(4) manufactures the xtra equipment.The incident occurred in (b)(6).This medwatch report is filed on behalf of sorin group.Sorin group received a report that samples taken from blood processed using an xtra autotransfusion device showed hemolysis.It was also reported that the patient experienced hypotension but there was no injury.A report against the disposable was filed under medwatch number 9680841-2015-00413.The device was not returned to sorin group for investigation, but an investigation was performed by the customer.Follow-up communication with the customer has revealed that the reported issue was unrelated to the xtra autotransfusion device and the disposable.A pathologist analyzed the cell savor blood and was able to rule out any issues with the blood.After a full investigation, the facility concluded that the issue experienced by the patient was not related to cell salvage.The patient was on angiotensin-converting enzyme (ace) inhibitors at the time of the event, which are widely used as treatment for hypertension.Hypotension is a potential side effect of the use of these drugs.No further investigation is required as there is no indication that this issue was related to cell salvage.A review of the dhr was unable to identify any concessions, deviations or non-conformities relevant to the reported failure.No trend was identified for this type of issue.Sorin group (b)(4) will continue to monitor the market for trends related to this issue.
|